COVID-19 vaccination protects infected pregnant women from developing SARS-CoV-2 placentitis and decreases the risk for stillbirth
Placenta · 2024-03 · 148 · 38-43
DOI: 10.1016/j.placenta.2024.01.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2024-03. Verfasst von Gitte Zels und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University Hospitals Leuven, Leuven, Belgium. Electronic address: gitte.zels@kuleuven.be. Hauptthemen laut MEDLINE: COVID-19, Chorioamnionitis, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: The impact of COVID-19 infection in pregnant women remained unclear for a long time. Previous research showed that SARS-CoV-2 virus is able to infect the placenta, potentially causing significant lesions leading to placental insufficiency. The impact of maternal vaccination status on the prevalence of SARS-CoV-2 placentitis remains unclear. We characterized placental lesions in SARS-CoV-2 infected pregnant women and studied the impact of vaccination on placental involvement. METHODS: We retrospectively studied 180 placentas sent to the Department of Pathology in UZ Leuven or AZ Turnhout between January 2020 and August 2022, from non-vaccinated and vaccinated mothers suffering a SARS-CoV-2 proven infection during pregnancy. All reports and hematoxylin-eosin stained sections were revised by two pathologists to determine the presence of histopathological lesions that have been described in SARS-CoV-2 infection. SARS-CoV-2 immunostainings were available for a subgroup of 109 placentas. We gathered clinical data: date of delivery, date of positive serologic test result, vaccination status, SARS-CoV-2 variant and outcome of the pregnancy. RESULTS: Of the 180 placentas, 37,2% showed histopathological lesions and in 12,8% an immunohistochemically proven SARS-CoV-2 placentitis was present. SARS-CoV-2 immunohistochemical positivity was only seen in non-vaccinated mothers. The risk of fetal demise was more than 5 times higher for non-vaccinated mothers and their placentas showed significantly more syncytiotrophoblast necrosis and chronic histiocytic intervillositis compared to vaccinated mothers (both p < 0,001). DISCUSSION: Maternal vaccination was associated with a reduced risk of SARS-CoV-2 placentitis and stillbirth. This study provides new evidence of the protective effect of vaccination on the placenta.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University Hospitals Leuven, Leuven, Belgium. Electronic address: gitte.zels@kuleuven.be.
- Department of Pathology, University Hospitals Leuven, Leuven, Belgium; Department of Pathology, AZ Turnhout, Turnhout, Belgium.
- Department of Laboratory Medicine, AZ Turnhout, Turnhout, Belgium; Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.
- Department of Laboratory Medicine, AZ Turnhout, Turnhout, Belgium.
- Department of Gynecology and Obstetrics, AZ Turnhout, Turnhout, Belgium.
- Department of Gynecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium.
Zitieren
APA
Zels, G., Colpaert, C., Leenaerts, D., Nailis, H., Verheecke, M., De Catte, L., Richter, J., & Baldewijns, M. (2024). COVID-19 vaccination protects infected pregnant women from developing SARS-CoV-2 placentitis and decreases the risk for stillbirth. Placenta, 148, 38-43. https://doi.org/10.1016/j.placenta.2024.01.015
Vancouver
Zels G, Colpaert C, Leenaerts D, Nailis H, Verheecke M, De Catte L, et al. COVID-19 vaccination protects infected pregnant women from developing SARS-CoV-2 placentitis and decreases the risk for stillbirth. Placenta. 2024;148:38-43. doi:10.1016/j.placenta.2024.01.015
BibTeX
@article{Zels2024,
author = {Zels, Gitte and Colpaert, Cecile and Leenaerts, Dorien and Nailis, Heleen and Verheecke, Magali and De Catte, Luc and Richter, Jute and Baldewijns, Marcella},
title = {COVID-19 vaccination protects infected pregnant women from developing SARS-CoV-2 placentitis and decreases the risk for stillbirth},
journal = {Placenta},
year = {2024},
volume = {148},
pages = {38--43},
doi = {10.1016/j.placenta.2024.01.015}
}
EUVIMED